BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36317692)

  • 1. MicroRNAs: Small molecules with big impacts in liver injury.
    Abdel Halim AS; Rudayni HA; Chaudhary AA; Ali MAM
    J Cell Physiol; 2023 Jan; 238(1):32-69. PubMed ID: 36317692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases.
    Hwang S; Yang YM
    Arch Pharm Res; 2021 Jun; 44(6):574-587. PubMed ID: 34165701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases.
    Wang X; He Y; Mackowiak B; Gao B
    Gut; 2021 Apr; 70(4):784-795. PubMed ID: 33127832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of miRNAs in liver diseases: Potential therapeutic and clinical applications.
    Doghish AS; Elballal MS; Elazazy O; Elesawy AE; Elrebehy MA; Shahin RK; Midan HM; Sallam AM
    Pathol Res Pract; 2023 Mar; 243():154375. PubMed ID: 36801506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1.
    Martinez MA; Tural C; Franco S
    Viruses; 2022 May; 14(6):. PubMed ID: 35746590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients.
    Mjelle R; Dima SO; Bacalbasa N; Chawla K; Sorop A; Cucu D; Herlea V; Sætrom P; Popescu I
    BMC Cancer; 2019 Oct; 19(1):1007. PubMed ID: 31660891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in liver disease.
    Szabo G; Bala S
    Nat Rev Gastroenterol Hepatol; 2013 Sep; 10(9):542-52. PubMed ID: 23689081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
    Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
    J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH).
    Qi X; Lai J
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miRNAs as biomarkers in the diagnosis of liver disease.
    Wang S; Wang JQ; Lv XW
    Biomark Med; 2017 May; 11(6):491-501. PubMed ID: 28598214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro RNAs as Emerging Therapeutic Targets in Liver Diseases.
    Latief U; Tung GK; Per TS; Kaur M; Thakur S; Singh H; Jain SK
    Curr Protein Pept Sci; 2022; 23(6):369-383. PubMed ID: 35899959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes in liver pathology.
    Sato K; Meng F; Glaser S; Alpini G
    J Hepatol; 2016 Jul; 65(1):213-221. PubMed ID: 26988731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker.
    Bandopadhyay M; Bharadwaj M
    Gut Pathog; 2020; 12():23. PubMed ID: 32346400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs and liver disease.
    Otsuka M; Kishikawa T; Yoshikawa T; Yamagami M; Ohno M; Takata A; Shibata C; Ishibashi R; Koike K
    J Hum Genet; 2017 Jan; 62(1):75-80. PubMed ID: 27225852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.
    Nedaeinia R; Manian M; Jazayeri MH; Ranjbar M; Salehi R; Sharifi M; Mohaghegh F; Goli M; Jahednia SH; Avan A; Ghayour-Mobarhan M
    Cancer Gene Ther; 2017 Feb; 24(2):48-56. PubMed ID: 27982021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules.
    Ajit SK
    Sensors (Basel); 2012; 12(3):3359-69. PubMed ID: 22737013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal microRNAs in the development of essential hypertension and its potential as biomarkers.
    Tan PPS; Hall D; Chilian WM; Chia YC; Mohd Zain S; Lim HM; Kumar DN; Ching SM; Low TY; Md Noh MF; Pung YF
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1486-H1497. PubMed ID: 33577433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human.
    Musaddaq G; Shahzad N; Ashraf MA; Arshad MI
    Biomarkers; 2019 Mar; 24(2):103-109. PubMed ID: 30252499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
    Hochreuter MY; Dall M; Treebak JT; Barrès R
    Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.